Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors.

Ramanathan RK, Egorin MJ, Erlichman C, Remick SC, Ramalingam SS, Naret C, Holleran JL, TenEyck CJ, Ivy SP, Belani CP.

J Clin Oncol. 2010 Mar 20;28(9):1520-6. doi: 10.1200/JCO.2009.25.0415. Epub 2010 Feb 22.

2.

Cisplatin abrogates the geldanamycin-induced heat shock response.

McCollum AK, Lukasiewicz KB, Teneyck CJ, Lingle WL, Toft DO, Erlichman C.

Mol Cancer Ther. 2008 Oct;7(10):3256-64. doi: 10.1158/1535-7163.MCT-08-0157.

3.

P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.

McCollum AK, TenEyck CJ, Stensgard B, Morlan BW, Ballman KV, Jenkins RB, Toft DO, Erlichman C.

Cancer Res. 2008 Sep 15;68(18):7419-27. doi: 10.1158/0008-5472.CAN-07-5175.

4.

HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.

Haluska P, Carboni JM, TenEyck C, Attar RM, Hou X, Yu C, Sagar M, Wong TW, Gottardis MM, Erlichman C.

Mol Cancer Ther. 2008 Sep;7(9):2589-98. doi: 10.1158/1535-7163.MCT-08-0493. Epub 2008 Sep 2.

5.

Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism.

McCollum AK, Teneyck CJ, Sauer BM, Toft DO, Erlichman C.

Cancer Res. 2006 Nov 15;66(22):10967-75.

6.

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.

Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC.

Cancer Res. 2003 May 15;63(10):2462-9.

7.

Intraperitoneal therapy of ovarian cancer using an engineered measles virus.

Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ.

Cancer Res. 2002 Aug 15;62(16):4656-62.

8.

Metabolic adaptation of the fetal and postnatal ovine heart: regulatory role of hypoxia-inducible factors and nuclear respiratory factor-1.

Nau PN, Van Natta T, Ralphe JC, Teneyck CJ, Bedell KA, Caldarone CA, Segar JL, Scholz TD.

Pediatr Res. 2002 Aug;52(2):269-78.

PMID:
12149506
9.

Thyroid hormone regulation of the NADH shuttles in liver and cardiac mitochondria.

Scholz TD, TenEyck CJ, Schutte BC.

J Mol Cell Cardiol. 2000 Jan;32(1):1-10.

PMID:
10652185
10.

Auschwitz memento.

TenEyck CS.

Nurs Spectr (Wash D C). 1998 Aug 10;8(16):19. No abstract available.

PMID:
10562160
11.

Agency nursing--too good to be true?

TenEyck CS.

Nurs Spectr (Wash D C). 1998 Dec 14;8(25):10, 28. No abstract available.

PMID:
10542670
12.

Ontogeny of malate-aspartate shuttle capacity and gene expression in cardiac mitochondria.

Scholz TD, Koppenhafer SL, tenEyck CJ, Schutte BC.

Am J Physiol. 1998 Mar;274(3):C780-8. doi: 10.1152/ajpcell.1998.274.3.C780.

PMID:
9530110
13.

A view from the other side.

TenEyck CS.

Revolution. 1997 Fall;7(3):76-7. No abstract available.

PMID:
9385207
14.

Developmental regulation of the alpha-glycerophosphate shuttle in porcine myocardium.

Scholz TD, Koppenhafer SL, TenEyck CJ, Schutte BC.

J Mol Cell Cardiol. 1997 Jun;29(6):1605-13.

PMID:
9220346
15.
17.

An efficient method for the extraction of DNA from formalin-fixed, paraffin-embedded tissue by sonication.

Heller MJ, Burgart LJ, TenEyck CJ, Anderson ME, Greiner TC, Robinson RA.

Biotechniques. 1991 Sep;11(3):372-4, 376-7.

PMID:
1931037
18.

Growth control in cerebral microvessel-derived endothelial cells.

Robinson RA, Teneyck CJ, Hart MN.

Brain Res. 1986 Oct 1;384(1):114-20.

PMID:
3491656
19.

Supplemental Content

Loading ...
Support Center